Oura Ring has turned a small titanium wearable into one of health tech’s most compelling businesses. But as it eyes a reported $11 billion IPO valuation, Ian Ash and Steve Mast ask the uncomfortable question: is Oura a durable company, or a brilliant feature waiting to be absorbed by Apple?

In this episode of Unsolicited Biz Advice, Ian and Steve unpack the rise of the smart-ring leader: its powerful biometric data, consumer traction, recurring subscription model, and growing foothold in healthcare, enterprise, and government use cases. They also challenge the assumptions behind the hype. A single-product company, a growing dependence on subscriptions, and the looming possibility of an Apple iRing create a strategic problem no amount of sleek industrial design can solve.

The hosts debate Oura’s best path forward. Should it double down on health-data intelligence and enterprise partnerships? Pursue a luxury-jewelry strategy that makes the ring a premium object rather than another gadget? Give away the hardware to own the subscription? Or skip the IPO altogether and seek a bold partnership with a company such as NVIDIA to build an alternative consumer-health ecosystem?

This is not a conversation about whether Oura makes a good ring. It is about whether it can build a moat before the giants decide the category matters.

Key Takeaways

• Oura’s real asset may be its data, not its ring. Its long-running biometric dataset and healthcare integrations could be more defensible than the hardware form factor alone.
• Subscription revenue is strategically valuable, and increasingly fragile. Recurring revenue supports a stronger business model, but consumer subscription fatigue creates genuine retention and pricing risk.
• Apple is the existential competitive threat. An Apple smart ring could benefit immediately from deep ecosystem integration, enormous distribution, and the option to compete without a separate subscription.
• Healthcare and enterprise can create a stronger moat. Clinical partnerships, interoperability, insurance, military, and government relationships could give Oura protection that consumer hardware cannot.
• Premium positioning may be Oura’s best consumer defense. A luxury partnership or higher-end product line could reposition Oura as meaningful jewelry with technology, rather than technology that happens to be worn as jewelry.

If you were sitting across from Oura’s leadership team, would you push ahead with the IPO, sell before Apple enters, or bet everything on becoming the intelligence layer for personal health? Tune in for the debate, and the unsolicited advice.